Form 4: Veracyte VP Jonathan Wygant Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., reports acquisition of restricted stock units and disposal of common stock on March 6, 2025.
Summary
- On March 6, 2025, Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., acquired 13,288 shares of common stock in the form of restricted stock units.
- These restricted stock units vest 25% on March 2, 2026, and then 1/16 per quarter thereafter, contingent upon continued employment.
- On the same day, Wygant disposed of 13,288 shares of common stock.
- Following these transactions, Wygant beneficially owns 49,763 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, reflecting standard executive compensation practices. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings of company insiders.
Stakeholder Impact
- Shareholders are informed about changes in insider ownership, which can influence investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of transaction: acquisition of restricted stock units and disposal of common stock. |
| 03/02/2026 | First vesting date for 25% of the restricted stock units. |
| 03/10/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.